Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
The Practitioner
|
November 5, 2015
New developments in metastatic prostate cancer therapy
Thubeena Manickavasagar, Clare Gilson, Simon Chowdhury, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 3, 2026
"Hiding in Plain Sight: The Neuro-Protective Benefit of Tropomyosin Receptor Kinase Inhibition in Non-Neurotrophic Receptor Tyrosine Kinase-Driven Lung Cancers": Supporting a Neuroprotective Effect of Lorlatinib Across ALK and ROS1 Targets
David König, Thubeena Manickavasagar, Dharmisha Chauhan, et al.
Breast (Edinburgh, Scotland)
|
April 27, 2018
Outcomes of systemic therapy for advanced triple-negative breast cancer: A single centre experience
Nicolò Matteo Luca Battisti, David Okonji, Thubeena Manickavasagar, et al.
Maternal & Child Nutrition
|
December 13, 2012
Vitamin D deficiency in pregnancy - still a public health issue
Trixie McAree, Benjamin Jacobs, Thubeena Manickavasagar, et al.
Insights Into Imaging
|
November 19, 2023
Weakly supervised segmentation models as explainable radiological classifiers for lung tumour detection on CT images
Robert O'Shea, Thubeena Manickavasagar, Carolyn Horst, et al.
JTO Clinical and Research Reports
|
August 2, 2024
Successful Lorlatinib Rechallenge After Severe Drug-Induced Psychosis in ALK-Positive Metastatic NSCLC: A Case Report
Alexius John, Joanna Vick, Sarah Sarker, et al.
International Urology and Nephrology
|
April 9, 2026
Renal medullary carcinoma: a systematic review of clinical and radiological findings
William Weston, Cherry Sit, Derfel Ap Dafydd, et al.
Radiology
|
March 31, 2026
Independent Testing of Published CT Models for PD-L1 Status in Non-Small Cell Lung Cancer
Robert O'Shea, Carolyn Horst, Thubeena Manickavasagar, et al.
European Radiology
|
February 22, 2024
Predicting programmed death-ligand 1 (PD-L1) expression with fluorine-18 fluorodeoxyglucose ([<sup>18</sup>F]FDG) positron emission tomography/computed tomography (PET/CT) metabolic parameters in resectable non-small cell lung cancer
Daniel Johnathan Hughes, Eleni Josephides, Robert O'Shea, et al.
Lung Cancer Management
|
June 4, 2021
HER3 expression and MEK activation in non-small-cell lung carcinoma
Thubeena Manickavasagar, Wei Yuan, Suzanne Carreira, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
The Practitioner
|
November 5, 2015
New developments in metastatic prostate cancer therapy
Thubeena Manickavasagar, Clare Gilson, Simon Chowdhury, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 3, 2026
"Hiding in Plain Sight: The Neuro-Protective Benefit of Tropomyosin Receptor Kinase Inhibition in Non-Neurotrophic Receptor Tyrosine Kinase-Driven Lung Cancers": Supporting a Neuroprotective Effect of Lorlatinib Across ALK and ROS1 Targets
David König, Thubeena Manickavasagar, Dharmisha Chauhan, et al.
Breast (Edinburgh, Scotland)
|
April 27, 2018
Outcomes of systemic therapy for advanced triple-negative breast cancer: A single centre experience
Nicolò Matteo Luca Battisti, David Okonji, Thubeena Manickavasagar, et al.
Maternal & Child Nutrition
|
December 13, 2012
Vitamin D deficiency in pregnancy - still a public health issue
Trixie McAree, Benjamin Jacobs, Thubeena Manickavasagar, et al.
Insights Into Imaging
|
November 19, 2023
Weakly supervised segmentation models as explainable radiological classifiers for lung tumour detection on CT images
Robert O'Shea, Thubeena Manickavasagar, Carolyn Horst, et al.
JTO Clinical and Research Reports
|
August 2, 2024
Successful Lorlatinib Rechallenge After Severe Drug-Induced Psychosis in ALK-Positive Metastatic NSCLC: A Case Report
Alexius John, Joanna Vick, Sarah Sarker, et al.
International Urology and Nephrology
|
April 9, 2026
Renal medullary carcinoma: a systematic review of clinical and radiological findings
William Weston, Cherry Sit, Derfel Ap Dafydd, et al.
Radiology
|
March 31, 2026
Independent Testing of Published CT Models for PD-L1 Status in Non-Small Cell Lung Cancer
Robert O'Shea, Carolyn Horst, Thubeena Manickavasagar, et al.
European Radiology
|
February 22, 2024
Predicting programmed death-ligand 1 (PD-L1) expression with fluorine-18 fluorodeoxyglucose ([<sup>18</sup>F]FDG) positron emission tomography/computed tomography (PET/CT) metabolic parameters in resectable non-small cell lung cancer
Daniel Johnathan Hughes, Eleni Josephides, Robert O'Shea, et al.
Lung Cancer Management
|
June 4, 2021
HER3 expression and MEK activation in non-small-cell lung carcinoma
Thubeena Manickavasagar, Wei Yuan, Suzanne Carreira, et al.
Page
of 2